Cover Image
市場調查報告書

三次元細胞培養的全球市場的預測 ∼2022年:無支架型 (懸滴、生物反應器)、微流體、磁浮

3D Cell Culture Market by Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 363063
出版日期 內容資訊 英文 142 Pages
訂單完成後即時交付
價格
Back to Top
三次元細胞培養的全球市場的預測 ∼2022年:無支架型 (懸滴、生物反應器)、微流體、磁浮 3D Cell Culture Market by Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) - Global Forecast to 2022
出版日期: 2017年11月08日 內容資訊: 英文 142 Pages
簡介

全球三次元細胞培養的市場在預測期間內預計以20.3%的年複合成長率發展,從2017年的6億8280萬美元,成長到2022年的17億230萬美元的規模。對動物實驗的替代手法的開發的焦點擴大,政府及民間投資者的資金供給計畫,技術的發展,新產品的市場投入,意識的擴大等的要素促進該市場的成長。

本報告提供全球三次元細胞培養的市場調查,市場及技術概要,市場成長的影響因素及市場機會分析,各產品、用途、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境與市場佔有率,主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 各產品市場
  • 歐洲市場:各類型
  • 各用途市場
  • 各終端用戶市場
  • 地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 推動要素
    • 阻礙因素
    • 市場機會
    • 課題

第6章 市場分析:各產品

  • 簡介
  • 支架型
    • 水凝膠/ECM類比
    • 固態支架
    • MICROPATTERNED SURFACES
  • 無支架型
    • 超低黏合板
    • 懸滴板
    • 3D生物反應器
    • 3D培養皿
  • 微流體
  • 磁浮 & 3D生物印刷

第7章 市場分析:各用途

  • 簡介
  • 癌症、幹細胞研究
  • 藥物研發、毒性檢驗
  • 組織工程、再生醫療

第8章 市場分析:各終端用戶

  • 簡介
  • 醫藥品、生物科技企業
  • 研究機關

第9章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他
  • 亞太地區
  • 其他地區

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢
    • 協定、聯盟、合作
    • 新產品的投入
    • 擴張
    • 收購

第11章 企業簡介

  • THERMO FISHER SCIENTIFIC
  • CORNING
  • MERCK
  • LONZA
  • REPROCELL
  • 3D BIOTEK
  • EMULATE
  • GLOBAL CELL SOLUTIONS
  • HAMILTON
  • INSPHERO
  • KURARAY CO. LTD.
  • MIMETAS
  • NANO3D BIOSCIENCES
  • SYNTHECON
  • QGEL

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 4414

"Global 3D cell culture market projected to grow at a CAGR of 20.3%"

The 3D cell culture market is expected to reach USD 1,702.3 million by 2022 from USD 682.8 million in 2017, at a CAGR of 20.3%. The rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of the 3D cell culture market. On the other hand, market growth may be limited to a certain extent due to the lack of infrastructure for 3D cell-based research.

"Scaffold-based 3D cell culture products are expected to grow at the highest CAGR during the forecast period"

By product, the 3D cell culture market is segmented into scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, and magnetic levitation and 3D bioprinting. The scaffold-based 3D cell culture products segment is projected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the ability of scaffold-based products to mimic in vivo conditions, thus driving their adoption among end users.

"Cancer and stem cell research segment is expected to dominate the market during the forecast period"

Based on the applications, the 3D cell culture market is segmented into cancer and stem cell research, drug discovery and toxicology testing, and tissue engineering and regenerative medicine. The cancer and stem cell research segment is expected to dominate the market during the forecast period. The increasing incidence of cancer and significant funding initiatives for cancer research from government as well as private organizations are supporting the growth of this application segment.

"Europe to witness high growth during the forecast period"

In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Europe is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the growing prevalence of cancer, increasing venture capital investments, availability of technologically advanced products, strategic expansion of market players, and growing awareness of 3D cell culture through various conferences, symposia, workshops, and forums.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 25%; Tier 2 - 30%; Tier 3 - 45%.
  • By Designation: C-level- 25%; D-level- 40%; others- 35%.
  • By Region: North America-41%; Europe-30%; Asia-24%; RoW-5%.

List of companies profiled in the report:

  • Thermo Fisher (US
  • Corning (US)
  • Lonza (Switzerland)
  • Merck (Germany)
  • ReproCELL (Japan)
  • InSphero (Switzerland)
  • Global Cell Solutions (US)
  • Synthecon (US)
  • 3D Biotek (US)
  • Kuraray (Japan)
  • Hamilton Company (US)
  • Mimetas (Netherlands)
  • Emulate (US)
  • Nano3D Biosciences (US)
  • QGel (Switzerland)

Research Coverage:

The report provides an overview of the 3D cell culture market. It aims at estimating the market size and future growth potential of this market across different segments such as product, applications, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall 3D cell culture market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
  • 2.2. SECONDARY DATA
    • 2.2.1. SECONDARY SOURCES
  • 2.3. PRIMARY DATA
    • 2.3.1. PRIMARY SOURCES
    • 2.3.2. INDUSTRY INSIGHTS
  • 2.4. MARKET SIZE ESTIMATION
  • 2.5. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.6. MARKET SHARE ESTIMATION
  • 2.7. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. 3D CELL CULTURE MARKET OVERVIEW
  • 4.2. 3D CELL CULTURE MARKET, BY PRODUCT
  • 4.3. EUROPE: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE
  • 4.4. 3D CELL CULTURE MARKET, BY APPLICATION
  • 4.5. 3D CELL CULTURE MARKET, BY END USER
  • 4.6. 3D CELL CULTURE MARKET: GEOGRAPHIC SNAPSHOT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Focus on developing alternatives to animal testing
      • 5.2.1.2. Availability of funding for research
      • 5.2.1.3. Technological advancements & new product launches
      • 5.2.1.4. Growing awareness
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Lack of infrastructure
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emergence of microfluidics-based 3D cell culture
      • 5.2.3.2. Regenerative medicine, an alternative to organ transplantation
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Lack of consistency in 3D cell culture products

6. 3D CELL CULTURE MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SCAFFOLD-BASED 3D CELL CULTURE
    • 6.2.1. HYDROGELS/ECM ANALOGS
    • 6.2.2. SOLID SCAFFOLDS
    • 6.2.3. MICROPATTERNED SURFACES
  • 6.3. SCAFFOLD-FREE 3D CELL CULTURE
    • 6.3.1. LOW-ADHESION MICROPLATES
    • 6.3.2. HANGING DROP PLATES
    • 6.3.3. 3D BIOREACTORS
    • 6.3.4. 3D PETRI DISHES
  • 6.4. MICROFLUIDICS-BASED 3D CELL CULTURE
  • 6.5. MAGNETIC LEVITATION & 3D BIOPRINTING

7. 3D CELL CULTURE MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. CANCER AND STEM CELL RESEARCH
  • 7.3. DRUG DISCOVERY AND TOXICOLOGY TESTING
  • 7.4. TISSUE ENGINEERING AND REGENERATIVE MEDICINE

8. 3D CELL CULTURE MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.3. RESEARCH INSTITUTES

9. 3D CELL CULTURE MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. UK
    • 9.3.3. FRANCE
    • 9.3.4. REST OF EUROPE (ROE)
  • 9.4. ASIA PACIFIC (APAC)
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 10.3.2. PRODUCT LAUNCHES AND APPROVALS
    • 10.3.3. EXPANSIONS
    • 10.3.4. ACQUISITIONS

11. COMPANY PROFILES (Business Overview, Strength of product Portfolio, Business Strategy Excellence, Recent Developments,)*

  • 11.1. THERMO FISHER SCIENTIFIC
  • 11.2. CORNING
  • 11.3. MERCK
  • 11.4. LONZA
  • 11.5. REPROCELL
  • 11.6. 3D BIOTEK
  • 11.7. EMULATE
  • 11.8. GLOBAL CELL SOLUTIONS
  • 11.9. HAMILTON
  • 11.10. INSPHERO
  • 11.11. KURARAY
  • 11.12. MIMETAS
  • 11.13. NANO3D BIOSCIENCES
  • 11.14. SYNTHECON
  • 11.15. QGEL

*Details on Business Overview, Strength of product Portfolio, Business Strategy Excellence, Recent Developments, might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS FORM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: KEY PRODUCT LAUNCHES (2014-2017)
  • TABLE 2: RECENT CONFERENCES, WORKSHOPS, AND FORUMS FOR 3D CELL CULTURE MARKET
  • TABLE 3: 3D CELL CULTURE MARKET, BY PRODUCT, 2015-2022, USD MILLION
  • TABLE 4: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE, 2015-2022, USD MILLION
  • TABLE 5: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY REGION, 2015-2022, USD MILLION
  • TABLE 6: NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 7: EUROPE: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 8: HYDROGELS/ECM ANALOGS MARKET, BY REGION, 2015-2020, USD MILLION
  • TABLE 9: NORTH AMERICA: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 10: EUROPE: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 11: SOLID SCAFFOLDS MARKET, BY REGION, 2015-2020, USD MILLION
  • TABLE 12: NORTH AMERICA: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: EUROPE: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 14: MICROPATTERNED SURFACES MARKET, BY REGION, 2015-2020, USD MILLION
  • TABLE 15: NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 16: EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 17: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE, 2015-2020, USD MILLION
  • TABLE 18: LOW-ADHESION MICROPLATES MARKET, BY REGION, 2015-2020, USD MILLION
  • TABLE 19: NORTH AMERICA: LOW-ADHESION MICROPLATES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 20: EUROPE: LOW-ADHESION MICROPLATES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: HANGING DROP PLATES MARKET, BY REGION, 2015-2020, USD MILLION
  • TABLE 22: NORTH AMERICA: HANGING DROP PLATES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: EUROPE: HANGING DROP PLATES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: 3D BIOREACTORS MARKET, BY REGION, 2015-2020, USD MILLION
  • TABLE 25: NORTH AMERICA: 3D BIOREACTORS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 26: EUROPE: 3D BIOREACTORS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 27: 3D PETRI DISHES MARKET, BY REGION, 2015-2020, USD MILLION
  • TABLE 28: NORTH AMERICA: 3D PETRI DISHES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: EUROPE: 3D PETRI DISHES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY REGION, 2015-2020, USD MILLION
  • TABLE 31: NORTH AMERICA: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 32: EUROPE: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 33: MAGNETIC LEVITATION & 3D BIOPRINTING MARKET, BY REGION, 2015-2020, USD MILLION
  • TABLE 34: NORTH AMERICA: MAGNETIC LEVITATION & 3D BIOPRINTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 35: EUROPE: MAGNETIC LEVITATION & 3D BIOPRINTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: 3D CELL CULTURE MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 37: 3D CELL CULTURE MARKET FOR CANCER AND STEM CELL RESEARCH, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: NORTH AMERICA: 3D CELL CULTURE MARKET FOR CANCER AND STEM CELL RESEARCH, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: 3D CELL CULTURE MARKET FOR CANCER AND STEM CELL RESEARCH, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 40: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY AND TOXICITY TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY AND TOXICITY TESTING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: EUROPE: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY AND TOXICITY TESTING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 43: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 45: EUROPE: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 46: 3D CELL CULTURE MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 47: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 49: EUROPE: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 50: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 51: NORTH AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 52: EUROPE: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 53: 3D CELL CULTURE MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 54: NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 55: NORTH AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 56: NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 57: NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: NORTH AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 59: NORTH AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 60: US: 3D CELL CULTURE MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 61: US: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 62: US: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 63: US: 3D CELL CULTURE MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 64: US: 3D CELL CULTURE MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 65: CANADA: 3D CELL CULTURE MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 66: CANADA: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: CANADA: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: CANADA: 3D CELL CULTURE MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 69: CANADA: 3D CELL CULTURE MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 70: EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 71: EUROPE: 3D CELL CULTURE MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 72: EUROPE: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 73: EUROPE: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 74: EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 75: EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 76: GERMANY: 3D CELL CULTURE MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 77: GERMANY: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 78: GERMANY: SCAFFOLD-FREE 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 79: GERMANY: 3D CELL CULTURE MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 80: GERMANY: 3D CELL CULTURE MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 81: UK: 3D CELL CULTURE MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 82: UK: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 83: UK: SCAFFOLD-FREE 3D CELL CULTURE 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: UK: 3D CELL CULTURE MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 85: UK: 3D CELL CULTURE MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 86: FRANCE: 3D CELL CULTURE MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 87: FRANCE: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 88: FRANCE: SCAFFOLD-FREE 3D CELL CULTURE 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 89: FRANCE: 3D CELL CULTURE MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 90: FRANCE: 3D CELL CULTURE MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 91: ROE: 3D CELL CULTURE MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 92: ROE: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 93: ROE: SCAFFOLD-FREE 3D CELL CULTURE 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 94: ROE: 3D CELL CULTURE MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 95: ROE: 3D CELL CULTURE MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 96: APAC: 3D CELL CULTURE MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 97: APAC: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 98: APAC: SCAFFOLD-FREE 3D CELL CULTURE 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 99: APAC: 3D CELL CULTURE MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 100: APAC: 3D CELL CULTURE MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 101: ROW: 3D CELL CULTURE MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 102: ROW: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 103: ROW: SCAFFOLD-FREE 3D CELL CULTURE 3D CELL CULTURE MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 104: ROW : 3D CELL CULTURE MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 105: ROW: 3D CELL CULTURE MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 106: RECENT AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
  • TABLE 107: RECENT PRODUCT LAUNCH AND APPROVALS
  • TABLE 108: RECENT EXPANSIONS
  • TABLE 109: RECENT ACQUISITIONS
  • TABLE 110: EXCHANGE RATES (UTILIZED FOR CONVERSION OF EURO TO USD)
  • TABLE 111: EXCHANGE RATES (UTILIZED FOR CONVERSION OF CHF TO USD)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
  • FIGURE 3: MARKET ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 4: GLOBAL MARKET SIZE OF 3D CEL CULTURE MARKET : TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODODLOGY
  • FIGURE 6: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES
  • FIGURE 7: HYDROGELS/ECM ANALOGS TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 8: CANCER & STEM CELL RESEARCH SEGMENT TO DOMINATE THE 3D CELL CULTURE APPLICATIONS MARKET IN 2017
  • FIGURE 9: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE 3D CELL CULTURE END-USER MARKET
  • FIGURE 10: EUROPE TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 11: FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING TO DRIVE THE GROWTH OF THE MARKET
  • FIGURE 12: SCAFFOLD-BASED 3D CELL CULTURE TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 13: EUROPE: ULTRA-LOW ADHESION PLATES TO ACCOUNT FOR THE LARGEST SHARE OF THE SCAFFOLD-FREE 3D CELL CULTURE MARKET IN 2017
  • FIGURE 14: CANCER & STEM CELL RESEARCH TO WITNESS HIGH GROWTH FROM 2017 TO 2022
  • FIGURE 15: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE 3D CELL CULTURE MARKET IN 2017
  • FIGURE 16: GERMANY TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: 3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: SCAFFOLD-BASED 3D CELL CULTURE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: HYDROGELS/ECM ANALOGS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: LOW-ADHESION MICROPLATES TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 21: CANCER AND STEM CELL RESEARCH IS ESTIMATED TO BE THE LARGEST APPLICATION SEGMENT IN THE 3D CELL CULTURE MARKET
  • FIGURE 22: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE 3D CELL
  • FIGURE 23: CULTURE MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: NORTH AMERICA WILL CONTINUE TO DOMINATE THE 3D CELL CULTURE MARKET IN 2022
  • FIGURE 25: NORTH AMERICA: 3D CELL CULTURE MARKET SNAPSHOT
  • FIGURE 26: EUROPE: 3D CELL CULTURE MARKET SNAPSHOT
  • FIGURE 27: ASIA PACIFIC: 3D CELL CULTURE MARKET SNAPSHOT
  • FIGURE 28: ROW: 3D CELL CULTURE MARKET SNAPSHOT
  • FIGURE 29: MARKET EVOLUTION FRAMEWORK
  • FIGURE 30: 3D CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER (2016)
  • FIGURE 31: THERMO FISHER SCIENTIFIC, : COMPANY SNAPSHOT (2016)
  • FIGURE 32: CORNING: COMPANY SNAPSHOT (2016)
  • FIGURE 33: MERCK : COMPANY SNAPSHOT (2016)
  • FIGURE 34: LONZA: COMPANY SNAPSHOT (2016)
  • FIGURE 35: KURARAY: COMPANY OVERVIEW (2016)
Back to Top